世界の血管免疫芽球性T細胞リンパ腫（AILT）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3806 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、血管免疫芽球性T細胞リンパ腫（AILT）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血管免疫芽球性T細胞リンパ腫（AILT）治療の市場動向 ・企業の競争状況、市場シェア ・血管免疫芽球性T細胞リンパ腫（AILT）治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、その他） ・血管免疫芽球性T細胞リンパ腫（AILT）治療の用途別市場規模と予測2016-2027（病院、診療所、外来手術センター、その他） ・血管免疫芽球性T細胞リンパ腫（AILT）治療の北米市場規模2016-2027（アメリカ、カナダ） ・血管免疫芽球性T細胞リンパ腫（AILT）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血管免疫芽球性T細胞リンパ腫（AILT）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血管免疫芽球性T細胞リンパ腫（AILT）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血管免疫芽球性T細胞リンパ腫（AILT）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Seattle Genetics、Merck、Bristol-Myers Squibb、Genmab AS、Takeda Pharmaceutical、Eisai Co., Ltd.、Cellerant Therapeutics） ・結論

Market Analysis and Insights: Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market
The global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market.

Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Scope and Market Size
Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Novartis
Seattle Genetics
Merck
Bristol-Myers Squibb
Genmab AS
Takeda Pharmaceutical
Eisai Co., Ltd.
Cellerant Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Perspective (2016-2027)
2.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Growth Trends by Regions
2.2.1 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Industry Dynamic
2.3.1 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Trends
2.3.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Drivers
2.3.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Challenges
2.3.4 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Revenue
3.1.1 Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Revenue (2016-2021)
3.1.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue
3.4 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Concentration Ratio
3.4.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue in 2020
3.5 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Key Players Head office and Area Served
3.6 Key Players Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Solution and Service
3.7 Date of Enter into Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Breakdown Data by Type
4.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Type (2022-2027)

5 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Breakdown Data by Application
5.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2016-2027)
6.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type
6.2.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021)
6.2.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027)
6.2.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2027)
6.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application
6.3.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021)
6.3.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027)
6.3.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2027)
6.4 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country
6.4.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021)
6.4.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2016-2027)
7.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type
7.2.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2027)
7.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application
7.3.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2027)
7.4 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country
7.4.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type
8.2.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application
8.3.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region
8.4.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2016-2027)
9.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type
9.2.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2027)
9.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application
9.3.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2027)
9.4 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country
9.4.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type
10.2.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application
10.3.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country
10.4.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.1.4 Roche Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.2.4 Novartis Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Seattle Genetics
11.3.1 Seattle Genetics Company Details
11.3.2 Seattle Genetics Business Overview
11.3.3 Seattle Genetics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.3.4 Seattle Genetics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.3.5 Seattle Genetics Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.4.4 Merck Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Genmab AS
11.6.1 Genmab AS Company Details
11.6.2 Genmab AS Business Overview
11.6.3 Genmab AS Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.6.4 Genmab AS Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.6.5 Genmab AS Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Eisai Co., Ltd.
11.8.1 Eisai Co., Ltd. Company Details
11.8.2 Eisai Co., Ltd. Business Overview
11.8.3 Eisai Co., Ltd. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.8.4 Eisai Co., Ltd. Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.8.5 Eisai Co., Ltd. Recent Development
11.9 Cellerant Therapeutics
11.9.1 Cellerant Therapeutics Company Details
11.9.2 Cellerant Therapeutics Business Overview
11.9.3 Cellerant Therapeutics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction
11.9.4 Cellerant Therapeutics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
11.9.5 Cellerant Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Others
Table 5. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Regions (2016-2021)
Table 9. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Regions (2022-2027)
Table 11. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Trends
Table 12. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Drivers
Table 13. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Challenges
Table 14. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Restraints
Table 15. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment as of 2020)
Table 18. Ranking of Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Solution and Service
Table 22. Date of Enter into Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 65. Roche Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 70. Novartis Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Seattle Genetics Company Details
Table 73. Seattle Genetics Business Overview
Table 74. Seattle Genetics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 75. Seattle Genetics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 76. Seattle Genetics Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 80. Merck Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 85. Bristol-Myers Squibb Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Genmab AS Company Details
Table 88. Genmab AS Business Overview
Table 89. Genmab AS Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 90. Genmab AS Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 91. Genmab AS Recent Development
Table 92. Takeda Pharmaceutical Company Details
Table 93. Takeda Pharmaceutical Business Overview
Table 94. Takeda Pharmaceutical Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 95. Takeda Pharmaceutical Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 96. Takeda Pharmaceutical Recent Development
Table 97. Eisai Co., Ltd. Company Details
Table 98. Eisai Co., Ltd. Business Overview
Table 99. Eisai Co., Ltd. Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 100. Eisai Co., Ltd. Recent Development
Table 101. Cellerant Therapeutics Company Details
Table 102. Cellerant Therapeutics Business Overview
Table 103. Cellerant Therapeutics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product
Table 104. Cellerant Therapeutics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021) & (US$ Million)
Table 105. Cellerant Therapeutics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Others Features
Figure 5. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Report Years Considered
Figure 11. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Players in 2020
Figure 16. Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue in 2020
Figure 18. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2016-2027)
Figure 22. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2016-2027)
Figure 23. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Country (2016-2027)
Figure 24. United States Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Region (2016-2027)
Figure 40. China Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 61. Seattle Genetics Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 64. Genmab AS Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 66. Eisai Co., Ltd. Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 67. Cellerant Therapeutics Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---